AVIGI Therapeutics is leading the way in a new era of drug design and development.
AVIGI Therapeutics has raised $384K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2025.
AVIGI Therapeutics's investors include UNIIQ.
AVIGI Therapeutics is headquartered in Leiden, The Netherlands.
AVIGI Therapeutics is leading the way in a new era of drug design and development.
AVIGI Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AVIGI Therapeutics — Funding & Investors." VCBacked, April 4, 2025, https://www.vcbacked.co/company/avigi-therapeutics. Accessed August 2, 2026.
VCBacked. (2025). AVIGI Therapeutics — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/avigi-therapeutics
{{cite web |title=AVIGI Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avigi-therapeutics |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated